2004年12月
Clinicopathological features and prognostic factors of Japanese patients with "peripheral T-cell lymphoma, unspecified" diagnosed according to the WHO classification
LEUKEMIA RESEARCH
- 巻
- 28
- 号
- 12
- 開始ページ
- 1287
- 終了ページ
- 1292
- 記述言語
- 英語
- 掲載種別
- DOI
- 10.1016/j.leukres.2004.04.016
- 出版者・発行元
- PERGAMON-ELSEVIER SCIENCE LTD
Clinicopathological features of 36 patients, male: 58.3%; median: 68 years, with "peripheral T-cell lymphoma, unspecified" diagnosed by the WHO criteria were reviewed. Majority (69.4%) had stage IV disease with frequent involvements into bone marrow, spleen, liver, and skin. According to the IPI, 72.2% were categorized as high or high-intermediate risk group. CR and PR were achieved in 12 and 10 out of 31 patients treated by CHOP-based chemotherapy, respectively. One- and two-year overall survivals were 60.6 and 25.0%, respectively. Performance status, serum LDH, and B symptom were significant prognostic factors. Survival of CD4-/CD8+ cases, corresponding to cytotoxic T-cell lymphoma, was significantly worse than that of CD4+/CD8-. (C) 2004 Elsevier Ltd. All rights reserved.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.leukres.2004.04.016
- ISSN : 0145-2126
- Web of Science ID : WOS:000224780200008